Literature DB >> 11687610

Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor.

J Stolarov1, K Chang, A Reiner, L Rodgers, G J Hannon, M H Wigler, V Mittal.   

Abstract

We have engineered the ecdysone-inducible mammalian expression system for general retroviral delivery to cultured mammalian cells. We inducibly expressed PTEN in the glioblastoma cell line, U87MG, lacking this gene. Because nearly all cells are recruited on induction, we find both up- and down-regulated genes by cDNA microarray analysis. The changes we see are similar to those observed after treatment with LY294002, an inhibitor of phosphatidylinositol 3-OH kinase, fully consistent with the model that PTEN antagonizes phosphatidylinositol 3-OH kinase. Both treatments result in suppressed expression of the transforming growth factor (TGF)-beta gene and the genes of the cholesterol biosynthesis pathway. Our results illustrate the power of using a fully inducible expression system in conjunction with cDNA microarray analysis for exploring gene function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687610      PMCID: PMC60821          DOI: 10.1073/pnas.221450598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Fluorescent proteins in single- and multicolor flow cytometry.

Authors:  L Lybarger; R Chervenak
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.

Authors:  D M Li; H Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

4.  TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.

Authors:  D M Li; H Sun
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

5.  Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

Authors:  D No; T P Yao; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

7.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

8.  A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

9.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

10.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

View more
  21 in total

Review 1.  Application of inducible and targeted gene strategies to produce transgenic fish: a review.

Authors:  A Rocha; S Ruiz; A Estepa; J M Coll
Journal:  Mar Biotechnol (NY)       Date:  2004 Mar-Apr       Impact factor: 3.619

2.  Inhibition of neuronal phenotype by PTEN in PC12 cells.

Authors:  Sergei Musatov; Jill Roberts; Andrew I Brooks; John Pena; Simone Betchen; Donald W Pfaff; Michael G Kaplitt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

3.  The co-chaperone BAG3 regulates Herpes Simplex Virus replication.

Authors:  Christos A Kyratsous; Saul J Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

4.  Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry.

Authors:  Christopher Fiore; Dyane Bailey; Niamh Conlon; Xiaoqiu Wu; Neil Martin; Michelangelo Fiorentino; Stephen Finn; Katja Fall; Swen-Olof Andersson; Ove Andren; Massimo Loda; Richard Flavin
Journal:  J Clin Pathol       Date:  2012-03-23       Impact factor: 3.411

5.  PTEN inhibits adrenomedullin expression and function in brain tumor cells.

Authors:  Simone A Betchen; Sergei Musatov; Jill Roberts; John Pena; Michael G Kaplitt
Journal:  J Neurooncol       Date:  2006-07-05       Impact factor: 4.130

6.  Pathogenicity of Salmonella: SopE-mediated membrane ruffling is independent of inositol phosphate signals.

Authors:  Sandrine Deleu; Kuicheon Choi; Jeff M Reece; Stephen B Shears
Journal:  FEBS Lett       Date:  2006-02-17       Impact factor: 4.124

7.  Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63.

Authors:  Niklaus H Mueller; Matthew S Walters; Roland A Marcus; Laurie L Graf; Jessica Prenni; Don Gilden; Saul J Silverstein; Randall J Cohrs
Journal:  J Gen Virol       Date:  2010-01-20       Impact factor: 3.891

8.  Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.

Authors:  Lao H Saal; Peter Johansson; Karolina Holm; Sofia K Gruvberger-Saal; Qing-Bai She; Matthew Maurer; Susan Koujak; Adolfo A Ferrando; Per Malmström; Lorenzo Memeo; Jorma Isola; Pär-Ola Bendahl; Neal Rosen; Hanina Hibshoosh; Markus Ringnér; Ake Borg; Ramon Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

9.  Inducible, reversible, and stable RNA interference in mammalian cells.

Authors:  Sunita Gupta; Rebecca A Schoer; James E Egan; Gregory J Hannon; Vivek Mittal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

10.  PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.

Authors:  Frauke Leenders; Kristin Möpert; Anett Schmiedeknecht; Ansgar Santel; Frank Czauderna; Manuela Aleku; Silke Penschuck; Sibylle Dames; Maria Sternberger; Thomas Röhl; Axel Wellmann; Wolfgang Arnold; Klaus Giese; Jörg Kaufmann; Anke Klippel
Journal:  EMBO J       Date:  2004-07-29       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.